Sweco Leads Sustainable Südspidol Hospital Complex Project in Luxembourg

Sweco Leads Sustainable Südspidol Hospital Complex Project in Luxembourg

(IN BRIEF) Sweco, a leading technology consulting firm, will lead a consortium tasked with developing the new Südspidol hospital complex in Esch-sur-Alzette, Luxembourg, scheduled for full operation by 2033. Partnering with Centre Hospitalier Emile Mayrisch (CHEM), Sweco will oversee the entire design process, aiming to integrate technology, humanity, and nature into a holistic approach to healthcare. With a focus on sustainability, the project targets a DGNB certification, emphasizing state-of-the-art energy-efficient solutions. Sweco’s multidisciplinary approach and extensive healthcare expertise position it to coordinate over 50 stakeholders across five countries, ensuring the successful realization of this ambitious endeavor.

(PRESS RELEASE) STOCKHOLM, 14-Feb-2024 — /EuropaWire/ — Sweco will lead a consortium that will develop a new large-scale hospital complex in the south of Luxembourg, to be fully operational by 2033. The client is Centre Hospitalier Emile Mayrisch (CHEM) and Sweco will be responsible for managing the entire spectrum of design phases in the project.

Set to provide the population of the southern region of Luxembourg with modern healthcare, the new hospital “Südspidol” in the city of Esch-sur-Alzette is to be designed to incorporate technology, humanity, and nature in a holistic approach to healthcare. The hospital will have a gross floor area of 121,000 m² and approximately 600 beds, of which the majority are single rooms.

“Sweco is a market leader in technology consulting for the healthcare sector and we are excited to use our expertise to support CHEM in establishing the new Südspidol hospital in Luxembourg. This is an ambitious project aiming to obtain a DGNB certificate* for sustainability, and we will implement state-of-the-art energy-efficient solutions to meet that certification,” says Erwin Malcorps, Business Area President for Sweco in Belgium.

The strength of Sweco lies in a multidisciplinary approach and the pooling of knowledge across divisions and countries, in this specific project coordinating more than 50 stakeholders from different countries in five languages. Sweco will be managing the entire spectrum of design phases including advice to achieve high sustainability standards, permitting processes, tendering, budget control, construction management and commissioning.

*CHEM aims to obtain a DGNB certificate, a recognition by the Deutsche Gesellschaft für Nachhaltiges Bauen for sustainable construction projects. The DGNB system, which equally weighs ecology, economy, and sociocultural quality, offers a holistic approach to sustainability.

Sweco’s healthcare expertise
Sweco has significant experience of advising clients in healthcare, from supporting industrial clients within the healthcare and pharma sector, to planning, designing, building, and optimising hospitals and other health-oriented building projects. Sweco’s current and past experience from healthcare projects include private and public clients in Norway, Sweden, Belgium, among others.

Sweco plans and designs the sustainable communities and cities of the future. Together with our clients and the collective knowledge of our 22,000 architects, engineers, and other experts, we co-create
solutions to address urbanisation, capture the power of digitalisation, and make our societies more sustainable. Sweco is Europe’s leading engineering and architecture consultancy, with sales of approximately SEK 29 billion (EUR 2.5 billion) in 2023. The company is listed on Nasdaq Stockholm.
www.swecogroup.com

Media Contact:

Anna E Olsson
Head of Press
Sweco group
+46705573326
anna.e.olsson@sweco.se

SOURCE: Sweco AB